OsteoporosisNCT07419451
Health Literacy and Osteoporosis Awareness
An observational study of Osteoporosis and Health Literacy Level, run by Bandırma Onyedi Eylül University at 1 site in Turkey (Türkiye).
Trial summary
Osteoporosis (OP) is defined as a progressive metabolic bone disease characterized by low bone mass and deterioration of the microarchitecture of bone tissue, resulting in increased bone fragility and a higher risk of fractures. Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Osteoporosis, Health Literacy Level, Awareness and Knowledge Level
- What is being tested?
- Patients will only fill out a questionnaire.
- How many people
- 190 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 9 Jul 2025to 30 Mar 2026
- How long will I take part?
- 6 Months
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Study population: One of the distinguishing features of our study compared to previous research is the inclusion of both sexes. Another distinguishing aspect is the emphasis on the indication for osteoporosis screening in older adults, even in the absence of obvious risk factors such as chronic disease, medication use, or a history of fractures.
Who may be able to join
- Female patients aged 65 years and older
- Male patients aged 70 years and older
Who cannot join
- Cognitive dysfunction
- Dementia
- Uncontrolled psychiatric disorders
- Adjustment disorders
- Intellectual disability
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Naime Meriç KONAR EROL, Associate Professor contact
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Bandırma Onyedi Eylul University Faculty of Medicine
Balıkesir, Bandırma, 10200
Ayşe Güldem Kilciler, Prof. Dr., +9 0266 717 01 17, akilciler@bandirma.edu.tr
Nurten Nas Kırdar, Dr. Öğr. Üyesi
About this study
Official title: Health Literacy and Osteoporosis Awareness Levels Among Individuals in the Age Group at Risk for Osteoporosis: A Descriptive Cross-Sectional Study
Osteoporosis (OP) is defined as a progressive metabolic bone disease characterized by low bone mass and deterioration of the microarchitecture of bone tissue, resulting in increased bone fragility and a higher risk of fractures. Osteoporosis and related fractures constitute a significant public health problem in our increasingly aging world. It is currently estimated that more than 200 million people worldwide are affected by osteoporosis. The most important clinical outcome of osteoporosis is fragility fractures that occur as a result of low-energy trauma.
Health literacy is an important determinant of both individual and public health and is considered a fundamental component of patient-centered care. Health literacy is defined as the ability to obtain, process, and understand relevant health information in order to make appropriate health decisions, and limited health literacy is recognized as a global public health problem. Many patients have difficulty understanding their medical conditions, medications, and care instructions due to inadequate health literacy. Patients with limited health literacy often have insufficient understanding of diagnostic and treatment protocols, which poses a risk for potential misuse of healthcare services and poorer health outcomes. Low levels of health literacy are also associated with increased hospital admissions and higher mortality rates. In contrast, higher health literacy is associated with greater health knowledge and self-confidence.
Read more
Screening for the prevention of osteoporosis and related fractures can reduce fracture-associated mortality and morbidity. Such screening may be initiated by physicians through the evaluation of osteoporosis risk factors during clinical visits, or in some cases, based on patient demand, again guided by the physician's assessment of risk factors. One of the most important factors influencing patient demand is the level of osteoporosis awareness. Early diagnosis and treatment in at-risk patient groups before fractures occur can help prevent potential complications.
In recent years, numerous scientific studies have investigated levels of osteoporosis knowledge and awareness. Some of these studies have focused on specific populations, such as individuals with spinal cord injury, rheumatoid arthritis, or patients followed after osteoporotic fractures, while others have been conducted exclusively among women.
With increasing life expectancy and the growth of the elderly population, osteoporosis has become a more prominent health issue and is no longer limited to postmenopausal women, but rather represents a serious health problem affecting individuals of both sexes.
The aim of the present study is to assess health literacy and the level of osteoporosis awareness among individuals in the age group at risk for osteoporosis and to identify factors influencing these outcomes. One of the distinguishing features of our study compared to previous research is the inclusion of both sexes. Another distinguishing aspect is the emphasis on the indication for osteoporosis screening in older adults, even in the absence of obvious risk factors such as chronic disease, medication use, or a history of fractures. We hope that our study will contribute to the existing literature on osteoporosis, health literacy, and osteoporosis awareness.
Read the detailed description
Following approval from the institutional ethics committee, female patients aged 65 years and older and male patients aged 70 years and older who present to our outpatient clinic will be enrolled in the study. The study is designed as a cross-sectional study. All patients who apply to the Physical Medicine and Rehabilitation outpatient clinic and meet the inclusion criteria will be informed about the study, and those who provide written informed consent will be included. Participants' age, sex, and educational level will be recorded.
Health literacy will be assessed using the THLS-32 (Turkish Health Literacy Scale-32). The THLS-32 is a 32-item questionnaire that evaluates two domains (treatment and services; disease prevention/health promotion) and four processes (accessing health-related information, understanding health-related information, appraising health-related information, and applying/using health-related information). The Turkish validity and reliability of the Health Literacy Scale used in European countries were established in 2016, leading to the development of the THLS-32 scale. Each item is rated as very easy (1), easy (2), difficult (3), very difficult (4), or "I do not know" (5). The index score is calculated using the formula "index = (mean - 1) × (50/3)," resulting in a score range of 0-50. Cut-off values are defined as follows: 0-25 "inadequate health literacy," >25-33 "problematic/limited health literacy," >33-42 "adequate health literacy," and >42-50 "excellent health literacy." In this survey, the minimum score is 0 and the maximum score is 50. Higher scores indicate higher health literacy levels.
Osteoporosis awareness will be evaluated using the "Osteoporosis Awareness Scale," which has demonstrated Turkish validity and reliability. The final Turkish version of the Osteoporosis Awareness Scale consists of 27 items and five subscales. The 27 items are rated on a 4-point Likert scale as follows: "I know very well" (4), "I know" (3), "I know a little" (2), and "I do not know at all" (1). The total score ranges from a minimum of 27 to a maximum of 108. Although the scale has no reverse-scored items or cut-off points, higher total scores indicate greater osteoporosis awareness. The subscales include Bone Physiology (items 22-27), Preventive Behaviors (items 4, 5, 7, 8, 9, 10, and 21), Risk Factors (items 11-15), Exercise (items 1, 2, 3, and 6), and Characteristics of Osteoporosis (items 16-20).
The collected data will be analyzed using an appropriate statistical software program.
No tests, laboratory examinations, or interventions will be performed as part of this study.
No specific safety precautions are required during the implementation of the study.
Inclusion Criteria
Female patients aged 65 years and older
Male patients aged 70 years and older
Exclusion Criteria
Cognitive dysfunction
Dementia
Uncontrolled psychiatric disorders
Adjustment disorders
Intellectual disability
Statistical Analysis
The collected data will be analyzed using SPSS version 25.0 (IBM SPSS Statistics 25 software; Armonk, NY: IBM Corp.). Continuous variables will be presented as mean ± standard deviation, and categorical variables as numbers and percentages. When parametric test assumptions are met, comparisons between independent groups will be performed using the independent samples t-test and one-way analysis of variance (ANOVA). When parametric assumptions are not met, the Mann-Whitney U test and Kruskal-Wallis test will be used. Differences between categorical variables will be examined using the chi-square test. Relationships between continuous variables will be analyzed using Spearman or Pearson correlation analyses, appropriate regression models, and differences between categorical variables will be assessed using chi-square analysis. Multivariate regression analysis is planned to evaluate the relationships between variables. A p-value < 0.05 will be considered statistically significant.
At the beginning of the study, the sample size was calculated using the G*Power 3.1.9 software. Based on reference studies, a moderate effect size of d = 0.63 was assumed, and a total sample size of at least 64 participants (32 women and 32 men) was determined.
- Being tested
- Patients will only fill out a questionnaire.
- Keywords
- osteoporosis, health literacy, awareness
- Medical subject headings
- Osteoporosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Patients will only fill out a questionnaire.Other
Health literacy will be assessed using the TSOY-32 (Turkish Health Literacy Scale-32). The TSOY-32 is a 32-item questionnaire that evaluates two domains (treatment and services; disease prevention/health promotion) and four processes (accessing health-related information, understanding health-related information, appraising health-related information, and applying/using health-related information). The Turkish validity and reliability of the Health Literacy Scale used in European countries were established in 2016 by Okyay and Abacıgil, leading to the development of the TSOY-32 scale (12). Each item is rated as very easy (1), easy (2), difficult (3), very difficult (4), or "I do not know" (5). The index score is calculated using the formula "index = (mean - 1) × (50/3)," resulting in a score range of 0-50. Cut-off values are defined as follows: 0-25 "inadequate health literacy," >25-33 "problematic/limited health literacy," >33-42 "adequate health literacy," and >42-50 "excellent healt
| Study group | Role | What they receive |
|---|---|---|
| 95 men and 95 women | equal number of patients of both sexes Receives: Other: Patients will only fill out a questionnaire. |
What is being measured
The primary outcome is the main question the study is designed to answer.
THLS-32 (Turkish Health Literacy Scale-32)
THLS-32 (Turkish Health Literacy Scale-32) for health literacy. In this survey, the minimum score is 0 and the maximum score is 50. Higher scores indicate higher health literacy levels.
Measured: 6 months
Osteoporosis Awareness Scale
"Osteoporosis Awareness Scale" for osteoporosis awareness. The total score ranges from a minimum of 27 to a maximum of 108. Although the scale has no reverse-scored items or cut-off points, higher total scores indicate greater osteoporosis awareness.
Measured: 6 months
Secondary outcomes (6)
Relationship between age and THSL-32
-Relationship between age and THSL-32
Measured: 6 months
-Relationship between age and the "Osteoporosis Awareness Scale"
-Relationship between age and the "Osteoporosis Awareness Scale"
Measured: 6 months
-Relationship between gender and THSL-32
Relationship between gender and THSL-32
Measured: 6 months
-Relationship between gender and the "Osteoporosis Awareness Scale"
-Relationship between gender and the "Osteoporosis Awareness Scale"
Measured: 6 months
-Relationship between education level and THSL-32
-Relationship between education level and THSL-32
Measured: 6 months
Relationship between education level and the "Osteoporosis Awareness Scale"
Relationship between education level and the "Osteoporosis Awareness Scale"
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Feb 2026
- Study start9 Jul 2025
- Primary completion1 Mar 2026 (estimated)
- Study completion30 Mar 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for OsteoporosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 190 participants (estimated)
- Target duration
- 6 Months
Sponsor and investigators
- Lead sponsor
- Bandırma Onyedi Eylül University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nurten NAS KIRDAR, Bandırma Onyedi Eylül University
- Investigators
- Nurten Nas Kırdar, Dr. Öğr. Üyesi, Principal investigator, Bandırma Onyedi Eylül University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07419451
- Sponsor's protocol ID
- E-67961857-050.04-2500024943
- Status last verified
- Feb 2026
- First submitted
- 24 Jan 2026
- Last updated
- 19 Feb 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The data analysis and results of our scientific research have not yet been completed. The final version of our study will be shared with readers by being published in an academic journal in the field of medicine. If a suitable journal deems our study suitable for publication after the peer review process, other researchers will be able to read and benefit from this publication once it is released.
Publications
Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD; Scientific Advisory Council of Osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010 Nov 23;182(17):1864-73. doi: 10.1503/cmaj.100771. Epub 2010 Oct 12. No abstract available.
PubMed 20940232Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992 Nov;2(6):285-9. doi: 10.1007/BF01623184.
PubMed 1421796Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R; National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014 Oct;25(10):2359-81. doi: 10.1007/s00198-014-2794-2. Epub 2014 Aug 15.
PubMed 25182228Nas Kirdar N, Konar Erol NM. Health literacy and osteoporosis awareness levels among individuals in the age group at risk for osteoporosis: A descriptive cross-sectional study. J Back Musculoskelet Rehabil. 2026 Nov 1:10538127261502088. doi: 10.1177/10538127261502088. Online ahead of print.
PubMed 42968202
Study at a glance
From the registry record, last updated by the sponsor on 19 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Health Literacy and Osteoporosis Awareness Levels Among Individuals in the Age Group at Risk for Osteoporosis: A Descriptive Cross-Sectional Study
- ClinicalTrials.gov ID
- NCT07419451
- Acronym / sponsor ID
- E-67961857-050.04-2500024943
- Keywords
- osteoporosis, health literacy, awareness
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 190 participants (estimated)
- Lead sponsor
- Bandırma Onyedi Eylül UniversityUniversity, hospital or other
- Study start
- 9 Jul 2025 (actual)
- Primary completion
- 1 Mar 2026 (estimated)
- Study completion
- 30 Mar 2026 (estimated)
- First posted
- 19 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Osteoporosis (OP) is defined as a progressive metabolic bone disease characterized by low bone mass and deterioration of the microarchitecture of bone tissue, resulting in increased bone fragility and a higher risk of fractures. Osteoporosis and related fractures constitute a significant public health problem in our increasingly aging world. It is currently estimated that more than 200 million people worldwide are affected by osteoporosis. The most important clinical outcome of osteoporosis is fragility fractures that occur as a result of low-energy trauma.
Health literacy is an important determinant of both individual and public health and is considered a fundamental component of patient-centered care. Health literacy is defined as the ability to obtain, process, and understand relevant health information in order to make appropriate health decisions, and limited health literacy is recognized as a global public health problem. Many patients have difficulty understanding their medical conditions, medications, and care instructions due to inadequate health literacy. Patients with limited health literacy often have insufficient understanding of diagnostic and treatment protocols, which poses a risk for potential misuse of healthcare services and poorer health outcomes. Low levels of health literacy are also associated with increased hospital admissions and higher mortality rates. In contrast, higher health literacy is associated with greater health knowledge and self-confidence.
Screening for the prevention of osteoporosis and related fractures can reduce fracture-associated mortality and morbidity. Such screening may be initiated by physicians through the evaluation of osteoporosis risk factors during clinical visits, or in some cases, based on patient demand, again guided by the physician's assessment of risk factors. One of the most important factors influencing patient demand is the level of osteoporosis awareness. Early diagnosis and treatment in at-risk patient groups before fractures occur can help prevent potential complications.
In recent years, numerous scientific studies have investigated levels of osteoporosis knowledge and awareness. Some of these studies have focused on specific populations, such as individuals with spinal cord injury, rheumatoid arthritis, or patients followed after osteoporotic fractures, while others have been conducted exclusively among women.
With increasing life expectancy and the growth of the elderly population, osteoporosis has become a more prominent health issue and is no longer limited to postmenopausal women, but rather represents a serious health problem affecting individuals of both sexes.
The aim of the present study is to assess health literacy and the level of osteoporosis awareness among individuals in the age group at risk for osteoporosis and to identify factors influencing these outcomes. One of the distinguishing features of our study compared to previous research is the inclusion of both sexes. Another distinguishing aspect is the emphasis on the indication for osteoporosis screening in older adults, even in the absence of obvious risk factors such as chronic disease, medication use, or a history of fractures. We hope that our study will contribute to the existing literature on osteoporosis, health literacy, and osteoporosis awareness.
Detailed description
Following approval from the institutional ethics committee, female patients aged 65 years and older and male patients aged 70 years and older who present to our outpatient clinic will be enrolled in the study. The study is designed as a cross-sectional study. All patients who apply to the Physical Medicine and Rehabilitation outpatient clinic and meet the inclusion criteria will be informed about the study, and those who provide written informed consent will be included. Participants' age, sex, and educational level will be recorded.
Health literacy will be assessed using the THLS-32 (Turkish Health Literacy Scale-32). The THLS-32 is a 32-item questionnaire that evaluates two domains (treatment and services; disease prevention/health promotion) and four processes (accessing health-related information, understanding health-related information, appraising health-related information, and applying/using health-related information). The Turkish validity and reliability of the Health Literacy Scale used in European countries were established in 2016, leading to the development of the THLS-32 scale. Each item is rated as very easy (1), easy (2), difficult (3), very difficult (4), or "I do not know" (5). The index score is calculated using the formula "index = (mean - 1) × (50/3)," resulting in a score range of 0-50. Cut-off values are defined as follows: 0-25 "inadequate health literacy," >25-33 "problematic/limited health literacy," >33-42 "adequate health literacy," and >42-50 "excellent health literacy." In this survey, the minimum score is 0 and the maximum score is 50. Higher scores indicate higher health literacy levels.
Osteoporosis awareness will be evaluated using the "Osteoporosis Awareness Scale," which has demonstrated Turkish validity and reliability. The final Turkish version of the Osteoporosis Awareness Scale consists of 27 items and five subscales. The 27 items are rated on a 4-point Likert scale as follows: "I know very well" (4), "I know" (3), "I know a little" (2), and "I do not know at all" (1). The total score ranges from a minimum of 27 to a maximum of 108. Although the scale has no reverse-scored items or cut-off points, higher total scores indicate greater osteoporosis awareness. The subscales include Bone Physiology (items 22-27), Preventive Behaviors (items 4, 5, 7, 8, 9, 10, and 21), Risk Factors (items 11-15), Exercise (items 1, 2, 3, and 6), and Characteristics of Osteoporosis (items 16-20).
The collected data will be analyzed using an appropriate statistical software program.
No tests, laboratory examinations, or interventions will be performed as part of this study.
No specific safety precautions are required during the implementation of the study.
Inclusion Criteria
Female patients aged 65 years and older
Male patients aged 70 years and older
Exclusion Criteria
Cognitive dysfunction
Dementia
Uncontrolled psychiatric disorders
Adjustment disorders
Intellectual disability
Statistical Analysis
The collected data will be analyzed using SPSS version 25.0 (IBM SPSS Statistics 25 software; Armonk, NY: IBM Corp.). Continuous variables will be presented as mean ± standard deviation, and categorical variables as numbers and percentages. When parametric test assumptions are met, comparisons between independent groups will be performed using the independent samples t-test and one-way analysis of variance (ANOVA). When parametric assumptions are not met, the Mann-Whitney U test and Kruskal-Wallis test will be used. Differences between categorical variables will be examined using the chi-square test. Relationships between continuous variables will be analyzed using Spearman or Pearson correlation analyses, appropriate regression models, and differences between categorical variables will be assessed using chi-square analysis. Multivariate regression analysis is planned to evaluate the relationships between variables. A p-value < 0.05 will be considered statistically significant.
At the beginning of the study, the sample size was calculated using the G*Power 3.1.9 software. Based on reference studies, a moderate effect size of d = 0.63 was assumed, and a total sample size of at least 64 participants (32 women and 32 men) was determined.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 6 Months
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| 95 men and 95 women | – | Other: Patients will only fill out a questionnaire.equal number of patients of both sexes |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
- Study population
- One of the distinguishing features of our study compared to previous research is the inclusion of both sexes. Another distinguishing aspect is the emphasis on the indication for osteoporosis screening in older adults, even in the absence of obvious risk factors such as chronic disease, medication use, or a history of fractures.
Key inclusion criteria (2 listed)
- Female patients aged 65 years and older
- Male patients aged 70 years and older
Key exclusion criteria (5 listed)
- Cognitive dysfunction
- Dementia
- Uncontrolled psychiatric disorders
- Adjustment disorders
- Intellectual disability
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Patients will only fill out a questionnaire.Health literacy will be assessed using the TSOY-32 (Turkish Health Literacy Scale-32). The TSOY-32 is a 32-item questionnaire that evaluates two domains (treatment and services; disease prevention/health promotion) and four processes (accessing health-related information, understanding health-related information, appraising health-related information, and applying/using health-related information). The Turkish validity and reliability of the Health Literacy Scale used in European countries were established in 2016 by Okyay and Abacıgil, leading to the development of the TSOY-32 scale (12). Each item is rated as very easy (1), easy (2), difficult (3), very difficult (4), or "I do not know" (5). The index score is calculated using the formula "index = (mean - 1) × (50/3)," resulting in a score range of 0-50. Cut-off values are defined as follows: 0-25 "inadequate health literacy," >25-33 "problematic/limited health literacy," >33-42 "adequate health literacy," and >42-50 "excellent healt | Other | 95 men and 95 women |
Primary outcome
THLS-32 (Turkish Health Literacy Scale-32)
Time frame: 6 months
THLS-32 (Turkish Health Literacy Scale-32) for health literacy. In this survey, the minimum score is 0 and the maximum score is 50. Higher scores indicate higher health literacy levels.
Osteoporosis Awareness Scale
Time frame: 6 months
"Osteoporosis Awareness Scale" for osteoporosis awareness. The total score ranges from a minimum of 27 to a maximum of 108. Although the scale has no reverse-scored items or cut-off points, higher total scores indicate greater osteoporosis awareness.
6 secondary outcomes
Relationship between age and THSL-32
Time frame: 6 months
-Relationship between age and the "Osteoporosis Awareness Scale"
Time frame: 6 months
-Relationship between gender and THSL-32
Time frame: 6 months
-Relationship between gender and the "Osteoporosis Awareness Scale"
Time frame: 6 months
-Relationship between education level and THSL-32
Time frame: 6 months
Relationship between education level and the "Osteoporosis Awareness Scale"
Time frame: 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Feb 2026.
- Background: PubMed 20940232Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD; Scientific Advisory Council of Osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010 Nov 23;182(17):1864-73. doi: 10.1503/cmaj.100771. Epub 2010 Oct 12. No abstract available.
- Background: PubMed 1421796Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992 Nov;2(6):285-9. doi: 10.1007/BF01623184.
- Background: PubMed 25182228Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R; National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014 Oct;25(10):2359-81. doi: 10.1007/s00198-014-2794-2. Epub 2014 Aug 15.
- Derived from this study: PubMed 42968202Nas Kirdar N, Konar Erol NM. Health literacy and osteoporosis awareness levels among individuals in the age group at risk for osteoporosis: A descriptive cross-sectional study. J Back Musculoskelet Rehabil. 2026 Nov 1:10538127261502088. doi: 10.1177/10538127261502088. Online ahead of print.
- recommendationLink provided by the sponsor.
- Individual participant dataSharing planned: No. The data analysis and results of our scientific research have not yet been completed. The final version of our study will be shared with readers by being published in an academic journal in the field of medicine. If a suitable journal deems our study suitable for publication after the peer review process, other researchers will be able to read and benefit from this publication once it is released.
Related trials for Osteoporosis
RecruitingObservational study
A Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral Compression Fractures of (Suspected) Osteoporotic Origin.
Vertebra Compression Fracture
Active, not recruitingObservational study
The Impact of Osteosarcopenia on Falls, Kinesiophobia, and Quality of Life in Postmenopausal Women
Osteosarcopenia, Sarcopenia
Active, not recruitingPhase 2
TCM Formula vs. HMB in Pre-Frail Elders: Muscle Strength and Bone Status
Pre-Frailty, Sarcopenia
Not yet recruitingPhase 4
Romosozumab and Denosumab Combination Therapy for Osteoporosis
Postmenopausal Osteoporosis
RecruitingObservational study
Assessment and Comparison of Osteoporosis Risk Factors After Stroke
Stroke, Osteoporosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Naime Meriç KONAR EROL, Associate Professor contact
Nurten Nas Kırdar, Dr. Öğr. Üyesi principal investigator
Bandırma Onyedi Eylül University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Osteoporosis and Health Literacy Level, run by Bandırma Onyedi Eylül University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 19 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Nurten NAS KIRDAR, Dr. Öğr. Üyesi (+905415511691, nkirdar@bandirma.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
THLS-32 (Turkish Health Literacy Scale-32) (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07419451, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2026.